CR vs ZBH · P/E 38, rev $2.31B vs P/E 23, rev $4.26B
Crane Company (CR) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Crane Company (CR) is a specialty industrial machinery company listed on NYSE.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported CR revenue for 2025-12-31 was $2.31B. Net income was $366.6M. Revenue was up 323.6% from 2024-12-31 to 2025-12-31. CR currently screens at market cap $12.08B and trailing P/E 38.2.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
CR currently screens at market cap $12.08B and trailing P/E 38.2. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the CR and ZBH stock pages for the full models.
Not investment advice.